Inclusion Criteria:
  -  Pathologically confirmed intermediate- or high-risk prostate cancer
  -  Biochemical recurrence after radical prostatectomy (Definition: Serial elevation of PSA over 0.2 ng/mL and <=1.0 ng/mL)
  -  ECOG performance status 0-1
  -  Appropriate values of blood tests within 6 months after enrollment Absolute neutrophil count (ANC) ≥ 1500 cells/mm3 Platelets ≥ 50,000 cells/mm3 Hemoglobin ≥ 8.0 g/dl
  -  Appropriate values of kidney function within 6 months after enrollment Creatinine < 2.0 ng/dL
  -  Appropriate values of liver function within 6 months after enrollment total bilirubin < 1.5 X maximum normal value alanine aminotransferase or aspartate aminotransferase < 2.5 X maximum normal value
Exclusion Criteria:
  -  Clinically gross recurrent tumor
  -  Presence of distant metastasis
  -  Presence of pelvic LN metastasis
  -  History of pelvic irradiation
  -  History of cryotherapy or brachytherapy for prostate cancer
  -  Double primary cancer other than skin/thyroid cancer
  -  Combined serious morbidity
